Synklino Strengthens Management Team with Key Appointments

Synklino ApS, an emerging biotech company developing first-in-class breakthrough treatment to eliminate cytomegalovirus (CMV) infections in the transplant setting, today announces the appointment of Tolga Hassan as Chief Finance Officer (CFO) and Dr. Josefin-Beate (Josi) Holz as Chief Medical Officer (CMO). This announcement follows the recent closing of a financing round led by Eir Ventures and Vaekstfonden.

Read more….

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH